571 results
424B3
CVS
CVS Health Corp
7 May 24
Prospectus supplement
8:31am
02895
(800) 201-0938
investorinfo@cvshealth.com
S-v
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
The Private Securities Litigation … Island 02895
(800) 201-0938
investorinfo@cvshealth.com
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
The Private Securities Litigation
8-K
EX-99.1
CVS
CVS Health Corp
1 May 24
CVS Health Corporation Reports First Quarter 2024 Results and Revises Full-year 2024 Guidance
6:32am
-related integration costs, opioid litigation charges and the corresponding income tax benefit or expense related to the items excluded from adjusted … .
Cautionary statement concerning forward-looking statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward
8-K
bujc3bae3ufsms2owh9g
5 Mar 24
Regulation FD Disclosure
6:09am
8-K
EX-99.1
7rwnvieo g78tcgc
7 Feb 24
Results of Operations and Financial Condition
6:33am
8-K
yjq41skde3
5 Jan 24
CVS Health Announces Leadership Appointments
6:41am
8-K
EX-99.1
3lha40qlcjj kfjze
5 Dec 23
CVS Health highlights path to accelerating long-term growth
6:31am
8-K
EX-99.1
smpkicknl6kdf8
1 Nov 23
Results of Operations and Financial Condition
6:35am
8-K
knougxza31dkrg2scpn
16 Oct 23
CVS Health announces CFO Shawn Guertin to take leave of absence due to family health reasons
6:45am
8-K
tmvpurjfk xgq
13 Oct 23
Regulation FD Disclosure
5:22pm
8-K
t8ngf
11 Sep 23
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
x023s31hrw2asuc
23 Aug 23
CVS Health Launches Cordavis
4:22pm